Luque, M.; Sanz-Álvarez, M.; Morales-Gallego, M.; Madoz-Gúrpide, J.; Zazo, S.; Domínguez, C.; Cazorla, A.; Izarzugaza, Y.; Arranz, J.L.; Cristóbal, I.;
et al. Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer. Cancers 2022, 14, 6034.
https://doi.org/10.3390/cancers14246034
AMA Style
Luque M, Sanz-Álvarez M, Morales-Gallego M, Madoz-Gúrpide J, Zazo S, Domínguez C, Cazorla A, Izarzugaza Y, Arranz JL, Cristóbal I,
et al. Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer. Cancers. 2022; 14(24):6034.
https://doi.org/10.3390/cancers14246034
Chicago/Turabian Style
Luque, Melani, Marta Sanz-Álvarez, Miriam Morales-Gallego, Juan Madoz-Gúrpide, Sandra Zazo, Carolina Domínguez, Alicia Cazorla, Yann Izarzugaza, Juan Luis Arranz, Ion Cristóbal,
and et al. 2022. "Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer" Cancers 14, no. 24: 6034.
https://doi.org/10.3390/cancers14246034
APA Style
Luque, M., Sanz-Álvarez, M., Morales-Gallego, M., Madoz-Gúrpide, J., Zazo, S., Domínguez, C., Cazorla, A., Izarzugaza, Y., Arranz, J. L., Cristóbal, I., & Rojo, F.
(2022). Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer. Cancers, 14(24), 6034.
https://doi.org/10.3390/cancers14246034